A practical reference on certificate of analysis: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-13. Anything still debated is marked as such rather than presented as settled.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Sealed vial; reconstituted before laboratory use |
| Appearance | White to off-white solid | Visual descriptor used on certificates of analysis |
| Solubility class | Water-soluble | Dissolves in water and aqueous buffers |
| Reported mass, fragment | Near 889 Da | Value depends on the stated sequence |
| Reported mass, parent protein | Near 4963 Da | 43-residue thymosin beta-4 |
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
===== Rpn10 ===== Rpn10 was the first ubiquitin receptor identified on the proteasome. Rpn10 has a von Willebrand factor type A (VWA) attached to either a single Ubiquitin Interaction Motif (UIM), in yeast, or two UIMs in higher eukaryotes. The VWA domain binds between the base subcomplex and lid subcomplex of the 19S RP, while the UIM extends into a space over the AAA motor, though the UIM has not been seen in cryo-EM structures. NMR studies have shown that the UIM of Rpn10 binds mono-ubiquitin, and K48 di-ubiquitin with higher affinity. More recently, the C-terminus of Rpn10 in higher eukaryotes has been shown to bind an E3 ligase, UBE3A/E6AP (see Proteasomal Ligases).
Practical Physiology (1903) Recent Advances in Physiology (with Leonard E. Hill, 1905) Diabetes: its Pathological Physiology (1913) Physiology for dental students (with R. G. Pearce, 1915) Physiology and Biochemistry in Modern Medicine (1st edition 1918) Insulin and its Use in Diabetes (with W. R. Campbell, 1925) Carbohydrate Metabolism and Insulin (1926) The Fuel of life: Experimental Studies in Normal and Diabetic Animals (1928) Macleod, J.J.R., "Gluconeogenesis and the Energy Material of Muscle", The Australian Journal of Experimental Biology and Medical Science, Vol.9, No.1, (January 1932), pp. 119-125.
== Epidemiology == Sjögren's disease (SjD) is the third-most common rheumatic autoimmune disorder, behind rheumatoid arthritis and systemic lupus erythematosus. There are no geographical differences in the rates of Sjögren's. Sjögren's disease has been reported in all areas of the world, although regional rates have not been well studied. Depending on the criteria to determine prevalence, studies estimate the prevalence of Sjögren's at between 500,000 and 2 million people in the United States. Broader studies of Sjögren's prevalence vary widely, with some reports suggesting a prevalence of up to 3% of the population. A few studies have reported that the incidence of the syndrome ranges between three and six per 100,000 per year. Between 0.2 and 1.2% of the population is affected, with half having the primary form and half the secondary form. It is around 10 times more common in women than in men. Though the disease commonly begins in middle age, people of any age can be affected. Nine out of 10 Sjögren's patients are women. In addition to prevalence in women, having a first-degree relative with an autoimmune disease and previous pregnancies have been identified as epidemiological risk factors. Despite the lower risk for men, primary Sjögren's in men tends to represent a more severe form of the disease. The role of race and ethnicity in the prevalence of the disease is unknown. Although Sjögren's disease occurs in all age groups, the average age of onset is between 40 and 60. As many as half of all cases may be left undiagnosed or unreported.
Males expel urine from the bladder through the urethra, which passes through the prostate where it is joined by the ejaculatory ducts, and then onward through the penis. At the root of the penis (the proximal end of the corpus spongiosum) lies the external sphincter muscle, which relaxes during urination. This is a small sphincter of striated muscle tissue and is in healthy males, under voluntary control. Physiologically, urination involves coordination between the central, autonomic, and somatic nervous systems. In infants, some elderly individuals, and those with neurological injury, urination may occur as an involuntary reflex. Brain centers that regulate urination include the pontine micturition center, periaqueductal gray, and the cerebral cortex. During erection, these centers block the relaxation of the sphincter muscles, so as to act as a physiological separation of the excretory and reproductive function of the penis, and preventing urine from entering the upper portion of the urethra during ejaculation.
== External links == hepcidin at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Intrinsic LifeSciences - Hepcidin Research Facility, The BioIron Company Hepcidinanalysis.com - Service for Hepcidin measurements: Scientific Research, Patients and Clinical Trials Protein Data Bank Page PDBe-KB provides an overview of all the structure information available in the PDB for Human Hepcidin
Sources: en.wikipedia.org
Hitler, aiming to use the crisis as a pretext for war, now demanded not only the annexation of the Sudetenland but also the immediate military occupation of Bohemia, Moravia and Slovakia, thus giving the Czechoslovak army no time to adapt its defence measures to the new borders. Hitler, in a speech at the Sportpalast in Berlin, claimed that the Sudetenland was "the last territorial demand I have to make in Europe" and gave Czechoslovakia a deadline of 28 September 1938 at 2:00 p.m. to cede the Sudetenland to Germany or face war. To achieve a solution, the Italian dictator, Benito Mussolini, suggested a conference of the major powers in Munich, and on 29 September, Hitler, Daladier and Chamberlain met and agreed to Mussolini's proposal (actually prepared by Hermann Göring) and signed the Munich Agreement. They accepted the immediate occupation of the Sudetenland. The Czechoslovak government, though not party to the talks, submitted to compulsion and promised to abide by the agreement on 30 September. The Sudetenland was assigned to Germany between 1 and 10 October 1938. The Czech part of Czechoslovakia was subsequently invaded by Germany in March 1939, with a portion being annexed and the remainder turned into the Protectorate of Bohemia and Moravia. The Slovak part declared its independence from Czechoslovakia and became the Slovak Republic (Slovak State), a satellite state allied to Germany.
March 31, 2004: The Ministry Delegate for Parity and Professional Equality gains its autonomy. May 26, 2004: Law concerning divorce; the protection of the spouse victim of violence is taken into account. July 1, 2004: Decree concerning the conditions for performing voluntary terminations of pregnancy outside healthcare establishments and amending the Public Health Code (second part: Regulatory part). August 6, 2004: Law concerning bioethics. November 24, 2004: Plan to combat violence against women. November 24, 2004: Ordinance concerning the legislative part of the Code on the Entry and Residence of Foreigners and the Right of Asylum. March 23, 2006: Law concerning equal pay between women and men. April 5, 2006: Law on strengthening the prevention and repression of violence within couples or against minors. December 30, 2004: Law establishing the French Equal Opportunities and Anti-Discrimination Commission (HALDE). March 17, 2005: Decree concerning the family reunification of foreigners for the application of Book IV of the Code on the Entry and Residence of Foreigners and the Right of Asylum. April 2, 2005: Orientation and Program Law for the Future of the School, which emphasizes that it must "promote coeducation and equality between men and women." June 2, 2005: Creation of the Ministry Delegate for Social Cohesion and Parity. July 4, 2005: Ordinance reforming filiation. August 2, 2005: Law in favor of small and medium-sized enterprises; it notably includes provisions concerning the status of the collaborating spouse.
=== 1. Junctional epithelium === In clinical attachment loss, the junctional epithelium migrates apically along the root surface in response to chronic inflammation. As this epithelial attachment shifts downward, it defines the base of a periodontal pocket, which represents the clinical expression of attachment loss.
If there are three holes in a bucket (top, bottom, and middle), then the force vectors perpendicular to the inner container surface will increase with increasing depth – that is, a greater pressure at the bottom makes it so that the bottom hole will shoot water out the farthest. The force exerted by a fluid on a smooth surface is always at right angles to the surface. The speed of liquid out of the hole is
Miller (1992), professor of law at the University of Iowa Matthew Shum (1992), professor of economics at California Institute of Technology Victor Fleischer (1993), professor of law at University of California, Irvine Valerie Purdie Greenaway (1993), professor of psychology and first African-American to receive tenure in the sciences at Columbia University Michelle Hartman (1993), professor of Arabic and francophone literature at McGill University Soyoung Lee (1993), chief curator of the Harvard Art Museums Seth Rockman (1993), professor at Brown University, co-recipient of the 2010 Merle Curti Award David Rosen (1993), professor at Trinity College, Connecticut, recipient of the 2013 James Russell Lowell Prize David Eisenbach (1994), historian on media and politics; narrator, 10 Things You Don't Know About François Furstenberg (1994), historian at Johns Hopkins University Katerina Harvati (1994), professor of paleoanthropology at the University of Tübingen, identified the earliest known sample of the remains of modern humans outside Africa Ayanna Thompson (1994), professor of English at Arizona State University, president of the Shakespeare Association of America David H.
Sources: en.wikipedia.org
== In humans == There are many legends involving healing wounds by licking them or applying saliva. Saint Magdalena de Pazzi is said to have cured a nun of sores and scabs in 1589 by licking her limbs. The Roman Emperor Vespasian is said to have performed a healing of a blind man using his saliva. Pliny the Elder in his Natural History reported that a fasting woman's saliva is an effective cure for bloodshot eyes. In the Hebrew Bible saliva is associated with uncleanliness; however, in the Gospels there are three incidents where Jesus uses saliva to heal (Mark 7:33, Mark 8:23, John 9:6). Köstenberger suggests "by using saliva to cure a man, Jesus claims to possess unusual spiritual authority." There are potential health hazards in wound licking due to infection risk, especially in immunocompromised patients. Human saliva contains a wide variety of bacteria that are harmless in the mouth, but that may cause significant infection if introduced into a wound. A notable case was a diabetic man who licked his bleeding thumb following a minor bicycle accident, and subsequently had to have the thumb amputated after it became infected with Eikenella corrodens from his saliva.
The 200 year old doctrine has had different effects depending on the era in which it was employed but its central theme has stayed the same: to maintain US hegemony in trade routes, trade deals, security, and access in the Western Hemisphere.
[D]espite massive deployment of police and other resources to implement the UN Conventions, production and consumption of, and trafficking in, prohibited substances have increased exponentially over the past 30 years, representing what can only be described as a failure, which the police and judicial authorities also recognise as such ... [T]he policy of prohibiting drugs, based on the UN Conventions of 1961, 1971 and 1988, is the true cause of the increasing damage that the production of, trafficking in, and sale and use of illegal substances are inflicting on whole sectors of society, on the economy and on public institutions, eroding the health, freedom and life of individuals. The road to repeal would be difficult. Individual nations could withdraw from the treaty under the provisions of Article 30. However, as former UN drug official Cindy Fazey notes, the convention has no termination clause, and therefore would remain in effect even if only one signatory remained. The Transnational Radical Party report noted that denunciation is the only route to changing the control regime established by the treaty:
=== Nonspecific pain === Patients with uncomplicated back pain should be encouraged to remain active and to return to normal activities. The management goals when treating back pain are to achieve maximal reduction in pain intensity as rapidly as possible, to restore the individual's ability to function in everyday activities, to help the patient cope with residual pain, to assess for side effects of therapy and to facilitate the patient's passage through the legal and socioeconomic impediments to recovery. For many, the goal is to keep the pain at a manageable level to progress with rehabilitation, which then can lead to long-term pain relief. Also, for some people the goal is to use nonsurgical therapies to manage the pain and avoid major surgery, while for others surgery may represent the quickest path to pain relief. Not all treatments work for all conditions or for all individuals with the same condition, and many must try several treatment options to determine what works best for them. The present stage of the condition (acute or chronic) is also a determining factor in the choice of treatment. Only a minority of people with back pain (most estimates are 1–10%) require surgery.
Sources: en.wikipedia.org
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.
Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.
The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.
Dry lyophilized powder is usually kept frozen, desiccated, and out of direct light. Sealed vials are not opened until needed, because moisture uptake can degrade short peptides. Longer archival storage is often done at lower temperatures than routine working stock.